Dose-Finding Study of SC411 in Children With Sickle Cell Disease

NCT02973360 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Docosahexaenoic Acid
DRUG: Placebo

Sponsor

Micelle BioPharma Inc